(19)
(11) EP 2 323 686 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
03.07.2013 Bulletin 2013/27

(45) Mention of the grant of the patent:
15.05.2013 Bulletin 2013/20

(21) Application number: 09788056.1

(22) Date of filing: 27.08.2009
(51) International Patent Classification (IPC): 
A61K 38/22(2006.01)
 A61K 38/17(2006.01)
(86) International application number:
PCT/JP2009/065380
(87) International publication number:
WO 2010/024460 (04.03.2010 Gazette 2010/09)

(54)

ADIPONECTIN FOR TREATING PULMONARY DISEASE

ADIPONECTIN ZUR BEHANDLUNG VON LUNGENKRANKHEIT

ADIPONECTINE POUR LE TRAITEMENT D'UNE MALADIE PULMONAIRE

(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MT NL NO PL PT RO SE SI SK TR

(30) Priority: 27.08.2008 JP 2008217721

(43) Date of publication of application:
25.05.2011 Bulletin 2011/21

(60) Divisional application:
13158131.6

(73) Proprietor: Otsuka Pharmaceutical Co., Ltd.
Tokyo 101-8535 (JP)

(72) Inventors:
  • KOTOSAI, Kounori
    Osaka-shi Osaka 541-0045 (JP)
  • KIRIMA, Kazuyoshi
    Osaka-shi Osaka 541-0045 (JP)
  • KARASUTANI, Keiko
    Osaka-shi Osaka 541-0045 (JP)
  • OHMOTO, Yasukazu
    Osaka-shi Osaka 541-0045 (JP)
  • YABUUCHI, Yoichi
    Tokushima-shi Tokushima 771-0131 (JP)

(74) Representative: HOFFMANN EITLE 
Patent- und Rechtsanwälte Arabellastrasse 4
81925 München
81925 München (DE)


(56) References cited: : 
WO-A2-2007/087468
   
  • MIYAZAKI T; SHIMADA K; MOKUNO H; DAIDA H: "Adipocyte derived plasma protein, adiponectin, is associated with smoking status in patients with coronary artery disease." HEART (LONDON), vol. 89, no. 6, June 2003 (2003-06), pages 663-664, XP002563657 ISSN: 1355-6037
   
Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).